Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Oak Tree who wrote (1669)	9/19/2001 9:54:54 PM
From: WTSherman	Read Replies (1) of 2515

<C225, the lead drug, is a flash in the pan. Given that Bristol now owns 20%, it is likely that no one will "buy" the company. THere is a lot of hype around it. That might sell it but I'm not sure -- doctors can be quite fickle. Its all a matter of nerves and time. I still think its likely to get over-hyped and will be in for a big crash. < Well, you're nothing if not consistent. You've been singing this song for a long time and the stock has kept going up. There's no telling what will happen in the future, but, if you're logic is reduced to the fact that Bristol has a poor track record I think you're hanging by a fairly thin thread. Also, you conclusion that C225 is a "flash in the pan" seems more like wishful thinking than logical analysis.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next